Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery

Table 5 Random-effect logistic regression model showing the relationship between hypertonic saline and delirium, adjusted by CD14 + CD16+ monocytes

	OR	95% CI	P value
Hypertonic saline	0.86	0.14 to 5.33	0.874
CD14 + CD16+ monocytes, ≤ 34.40% versus > 34.40%	14.51	2.41 to 87.38	0.004
Age, per year	1.16	1.04 to 1.29	0.009
Sex, women versus men	0.31	0.09 to 0.99	0.048
ASA, II versus III	1.40	0.45 to 4.37	0.562
MMSE, per point	0.98	0.65 to 1.48	0.910
Hypertension, yes versus no	1.49	0.38 to 5.94	0.569
Diabetes, yes versus no	1.64	0.44 to 6.08	0.461
Coronary artery disease, yes versus no	1.34	0.35 to 5.09	0.669
Cerebral infarction, yes versus no	3.73	1.16 to 11.97	0.027
Duration of anesthesia, < 97 min versus > 97 min	1.27	0.38 to 4.27	0.694

ASA American Society of Anesthesiologists, MMSE mini-mental state examination, CI confidence interval, OR odds ratio. The ROC curve was calculated to evaluate the cut-off point of CD14 + CD16+ monocytes and the duration of anesthesia. The patients were divided into two groups based on the cut-off point. Significant results are italicized

ISSN: 1742-2094